PolyPid Historical Balance Sheet

PYPD Stock

USD 3.46 0.00 0.00%

Trend analysis of PolyPid balance sheet accounts such as Net Debt of 6.5 M, Accounts Payable of 1.3 M, Cash of 5.8 M or Non Current Assets Total of 7.8 M provides information on PolyPid's total assets, liabilities, and equity, which is the actual value of PolyPid to its prevalent stockholders. By breaking down trends over time using PolyPid balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining PolyPid latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether PolyPid is a good buy for the upcoming year.

PolyPid Inventory

201,285

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PolyPid. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.

About PolyPid Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of PolyPid at a specified time, usually calculated after every quarter, six months, or one year. PolyPid Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of PolyPid and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which PolyPid currently owns. An asset can also be divided into two categories, current and non-current.

PolyPid Balance Sheet Chart

At present, PolyPid's Net Debt is projected to increase significantly based on the last few years of reporting. The current year's Accounts Payable is expected to grow to about 1.3 M, whereas Total Current Liabilities is forecasted to decline to about 4 M.

Other Current Liab Total Current Liabilities Net Receivables Common Stock Shares Outstanding Total Liab

Add Fundamental

Total Current Liabilities

Total Current Liabilities is an item on PolyPid balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of PolyPid are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Most accounts from PolyPid's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into PolyPid current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PolyPid. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.At present, PolyPid's Net Debt is projected to increase significantly based on the last few years of reporting. The current year's Accounts Payable is expected to grow to about 1.3 M, whereas Total Current Liabilities is forecasted to decline to about 4 M.

	2021	2022	2023	2024 (projected)
Other Current Liabilities	3.9M	1.5M	2.0M	1.7M
Total Assets	44.2M	26.0M	15.4M	25.8M

Other Current Liab Total Assets

PolyPid balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Surpluse	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Short Long Term Debt Total
Total Assets		0.59	0.46	0.51	0.58	-0.24	-0.55	0.57	0.49	0.91	0.77	0.77	0.95	-0.52	0.52	0.05	-0.04	0.7	-0.31	0.91	0.59	0.0	0.95	0.53	0.47	0.73
Other Current Liab	0.59		0.77	0.1	0.71	-0.27	-0.67	0.84	0.71	0.52	0.18	0.18	0.55	-0.08	0.69	0.32	0.16	0.75	-0.69	0.76	0.49	0.23	0.56	0.7	0.62	0.67
Total Current Liabilities	0.46	0.77		0.12	0.94	0.21	-0.89	0.65	0.73	0.5	-0.01	-0.01	0.37	-0.45	0.66	0.53	0.04	0.81	-0.46	0.58	0.71	0.12	0.38	0.67	0.84	0.69
Total Stockholder Equity	0.51	0.1	0.12		0.23	0.13	-0.21	0.1	-0.06	0.52	0.51	0.51	0.45	-0.51	0.0	0.11	-0.88	0.21	-0.28	0.45	0.67	-0.86	0.46	0.0	0.19	-0.05
Property Plant And Equipment Net	0.58	0.71	0.94	0.23		0.22	-0.9	0.57	0.67	0.65	0.14	0.15	0.48	-0.53	0.61	0.5	-0.01	0.87	-0.33	0.63	0.75	0.08	0.49	0.62	0.89	0.76
Net Debt	-0.24	-0.27	0.21	0.13	0.22		-0.41	-0.38	-0.29	0.04	-0.15	-0.15	-0.47	-0.61	-0.14	0.67	-0.35	0.16	0.42	-0.26	0.48	-0.3	-0.46	-0.1	0.47	-0.24
Retained Earnings	-0.55	-0.67	-0.89	-0.21	-0.9	-0.41		-0.53	-0.62	-0.62	-0.14	-0.14	-0.37	0.69	-0.6	-0.76	0.03	-0.92	0.26	-0.59	-0.85	-0.07	-0.38	-0.63	-0.98	-0.69
Accounts Payable	0.57	0.84	0.65	0.1	0.57	-0.38	-0.53		0.63	0.33	0.01	0.02	0.63	0.05	0.54	0.14	0.16	0.61	-0.82	0.69	0.4	0.22	0.63	0.55	0.46	0.64
Cash	0.49	0.71	0.73	-0.06	0.67	-0.29	-0.62	0.63		0.37	0.0	0.0	0.49	-0.21	0.63	0.25	0.3	0.67	-0.44	0.57	0.37	0.36	0.49	0.64	0.58	0.83
Non Current Assets Total	0.91	0.52	0.5	0.52	0.65	0.04	-0.62	0.33	0.37		0.84	0.84	0.78	-0.68	0.47	0.18	-0.11	0.69	-0.12	0.85	0.66	-0.06	0.79	0.48	0.56	0.61
Non Currrent Assets Other	0.77	0.18	-0.01	0.51	0.14	-0.15	-0.14	0.01	0.0	0.84		1.0	0.69	-0.48	0.19	-0.18	-0.12	0.25	0.08	0.65	0.29	-0.13	0.69	0.19	0.06	0.27
Other Assets	0.77	0.18	-0.01	0.51	0.15	-0.15	-0.14	0.02	0.0	0.84	1.0		0.69	-0.48	0.19	-0.18	-0.13	0.26	0.07	0.66	0.3	-0.13	0.7	0.19	0.06	0.27
Cash And Short Term Investments	0.95	0.55	0.37	0.45	0.48	-0.47	-0.37	0.63	0.49	0.78	0.69	0.69		-0.31	0.51	-0.17	0.02	0.57	-0.4	0.84	0.41	0.04	1.0	0.51	0.28	0.72
Net Receivables	-0.52	-0.08	-0.45	-0.51	-0.53	-0.61	0.69	0.05	-0.21	-0.68	-0.48	-0.48	-0.31		-0.2	-0.55	0.37	-0.55	-0.19	-0.41	-0.79	0.3	-0.32	-0.23	-0.65	-0.34
Common Stock Total Equity	0.52	0.69	0.66	0.0	0.61	-0.14	-0.6	0.54	0.63	0.47	0.19	0.19	0.51	-0.2		0.24	0.26	0.77	-0.15	0.43	0.38	0.31	0.51	1.0	0.51	0.74
Common Stock Shares Outstanding	0.05	0.32	0.53	0.11	0.5	0.67	-0.76	0.14	0.25	0.18	-0.18	-0.18	-0.17	-0.55	0.24		-0.22	0.59	-0.05	0.08	0.69	-0.12	-0.16	0.29	0.81	0.2
Non Current Liabilities Total	-0.04	0.16	0.04	-0.88	-0.01	-0.35	0.03	0.16	0.3	-0.11	-0.12	-0.13	0.02	0.37	0.26	-0.22		0.07	0.17	-0.04	-0.53	0.99	0.01	0.25	-0.06	0.43
Capital Surpluse	0.7	0.75	0.81	0.21	0.87	0.16	-0.92	0.61	0.67	0.69	0.25	0.26	0.57	-0.55	0.77	0.59	0.07		-0.23	0.64	0.75	0.17	0.57	0.8	0.9	0.83
Inventory	-0.31	-0.69	-0.46	-0.28	-0.33	0.42	0.26	-0.82	-0.44	-0.12	0.08	0.07	-0.4	-0.19	-0.15	-0.05	0.17	-0.23		-0.58	-0.31	0.14	-0.41	-0.14	-0.21	-0.23
Other Current Assets	0.91	0.76	0.58	0.45	0.63	-0.26	-0.59	0.69	0.57	0.85	0.65	0.66	0.84	-0.41	0.43	0.08	-0.04	0.64	-0.58		0.6	0.01	0.86	0.44	0.5	0.64
Other Stockholder Equity	0.59	0.49	0.71	0.67	0.75	0.48	-0.85	0.4	0.37	0.66	0.29	0.3	0.41	-0.79	0.38	0.69	-0.53	0.75	-0.31	0.6		-0.44	0.42	0.41	0.84	0.41
Total Liab	0.0	0.23	0.12	-0.86	0.08	-0.3	-0.07	0.22	0.36	-0.06	-0.13	-0.13	0.04	0.3	0.31	-0.12	0.99	0.17	0.14	0.01	-0.44		0.03	0.31	0.04	0.49
Total Current Assets	0.95	0.56	0.38	0.46	0.49	-0.46	-0.38	0.63	0.49	0.79	0.69	0.7	1.0	-0.32	0.51	-0.16	0.01	0.57	-0.41	0.86	0.42	0.03		0.5	0.29	0.72
Common Stock	0.53	0.7	0.67	0.0	0.62	-0.1	-0.63	0.55	0.64	0.48	0.19	0.19	0.51	-0.23	1.0	0.29	0.25	0.8	-0.14	0.44	0.41	0.31	0.5		0.55	0.74
Property Plant Equipment	0.47	0.62	0.84	0.19	0.89	0.47	-0.98	0.46	0.58	0.56	0.06	0.06	0.28	-0.65	0.51	0.81	-0.06	0.9	-0.21	0.5	0.84	0.04	0.29	0.55		0.64
Short Long Term Debt Total	0.73	0.67	0.69	-0.05	0.76	-0.24	-0.69	0.64	0.83	0.61	0.27	0.27	0.72	-0.34	0.74	0.2	0.43	0.83	-0.23	0.64	0.41	0.49	0.72	0.74	0.64

Click cells to compare fundamentals

PolyPid Account Relationship Matchups

PolyPid balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	33.8M	75.8M	44.2M	26.0M	15.4M	25.8M
Other Current Liab	998K	1.9M	3.9M	1.5M	2.0M	1.7M
Total Current Liabilities	2.6M	2.9M	7.8M	8.6M	7.3M	4.0M
Total Stockholder Equity	30.9M	72.8M	36.2M	5.9M	(2.1M)	(2.2M)
Property Plant And Equipment Net	6.1M	5.9M	8.8M	11.7M	9.2M	5.3M
Net Debt	(3.9M)	(4.3M)	(9.8M)	5.2M	6.2M	6.5M
Retained Earnings	(93.3M)	(132.3M)	(174.6M)	(214.4M)	(238.3M)	(226.4M)
Accounts Payable	1.6M	974K	4.1M	1.1M	772K	1.3M
Cash	3.9M	4.3M	9.8M	8.6M	5.6M	5.8M
Non Current Assets Total	6.4M	28.3M	9.4M	11.8M	9.3M	7.8M
Non Currrent Assets Other	31K	22.2M	423K	99K	87K	82.7K
Other Assets	230K	22.8M	663K	99K	113.9K	108.2K
Cash And Short Term Investments	26.6M	44.5M	32.2M	12.6M	5.6M	5.3M
Net Receivables	42K	(251K)	118K	(213K)	(191.7K)	(182.1K)
Liabilities And Stockholders Equity	33.8M	75.8M	44.2M	26.0M	15.4M	25.8M
Non Current Liabilities Total	251K	193K	199K	11.5M	10.2M	9.7M
Other Current Assets	399K	2.3M	2.2M	1.1M	458K	878.4K
Other Stockholder Equity	124.2M	205.1M	210.8M	220.3M	236.2M	248.0M
Total Liab	2.8M	3.1M	8.0M	20.1M	17.5M	24.1M
Total Current Assets	27.4M	47.6M	34.8M	14.2M	6.1M	5.8M
Accumulated Other Comprehensive Income	(766K)	(1.2M)	(106.4M)	(3.1M)	(2.8M)	(3.0M)
Property Plant Equipment	6.1M	5.9M	8.8M	11.7M	13.4M	14.1M
Other Liab	251K	193K	199K	2.8M	3.3M	3.4M
Net Tangible Assets	(87.6M)	72.8M	36.2M	5.8M	6.7M	7.0M
Short Term Investments	14.0M	0.0	22.7M	40.2M	22.4M	4.0M
Non Current Liabilities Other	251K	193K	199K	174K	398K	273.2K
Net Invested Capital	30.9M	72.8M	36.2M	17.5M	8.3M	8.7M
Net Working Capital	24.8M	44.3M	27.0M	5.6M	(1.2M)	(1.2M)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

When determining whether PolyPid is a strong investment it is important to analyze PolyPid's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PolyPid's future performance. For an informed investment choice regarding PolyPid Stock, refer to the following important reports:

How To Invest In PolyPid

Details

Is PolyPid Stock a good investment?

Details

What is PolyPid's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.

You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PolyPid. If investors know PolyPid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PolyPid listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(7.22)

Return On Assets

(0.65)

Return On Equity

(4.97)

The market value of PolyPid is measured differently than its book value, which is the value of PolyPid that is recorded on the company's balance sheet. Investors also form their own opinion of PolyPid's value that differs from its market value or its book value, called intrinsic value, which is PolyPid's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PolyPid's market value can be influenced by many factors that don't directly affect PolyPid's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between PolyPid's value and its price as these two are different measures arrived at by different means. Investors typically determine if PolyPid is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PolyPid's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

PolyPid Historical Balance Sheet

PolyPid Inventory

201,285

About PolyPid Balance Sheet Analysis

PolyPid Balance Sheet Chart

Total Current Liabilities

Common Stock Shares Outstanding

Total Liab

PolyPid balance sheet Correlations

PolyPid Account Relationship Matchups

High Positive Relationship

High Negative Relationship

PolyPid balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Assets	+ 1.0	Non Currrent Assets Other
Total Current Assets	+ 1.0	Cash And Short Term Investments
Common Stock	+ 1.0	Common Stock Total Equity
Total Liab	+ 0.99	Non Current Liabilities Total
Cash And Short Term Investments	+ 0.95	Total Assets
Total Current Assets	+ 0.95	Total Assets

Property Plant Equipment	- 0.98	Retained Earnings
Capital Surpluse	- 0.92	Retained Earnings
Retained Earnings	- 0.9	Property Plant And Equipment Net
Retained Earnings	- 0.89	Total Current Liabilities
Non Current Liabilities Total	- 0.88	Total Stockholder Equity
Total Liab	- 0.86	Total Stockholder Equity